AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8441910 — intervention group
Group type: EXPERIMENTAL
Intervention: Furazolidone, 7.5 mg/kg/day (susceptible strains)
Number of subjects: 133
Study 8441910 — intervention group
Group type: COMPARATOR
Intervention: Chloramphenicol, 75 mg/kg/day (susceptible strains)
Number of subjects: 133
Study 8441910 — intervention group
Group type: EXPERIMENTAL
Intervention: Furazolidone (susceptible but chloramphenicol-resistant strains)
Number of subjects: 133
Study 30693609 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium (250 mg) plus Vitamin E (400 IU)
Number of subjects: 57
Study 29223349 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebellar cathodal tDCS (2-mA for 20 min)
Number of subjects: 24
Study 29223349 — intervention group
Group type: COMPARATOR
Intervention: Sham-tDCS
Number of subjects: 24
Study 29223349 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebellar anodal tDCS
Number of subjects: 24
Study 29223349 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebellar cathodal tDCS
Number of subjects: 24
Study 27040668 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin (GBP) superadded to a pre-existing regime containing amitriptyline (AMP)
Number of subjects: 77
Study 24178916 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral priming with device-assisted mirror symmetrical bimanual movements before upper limb physiotherapy, every weekday for 4 weeks.
Number of subjects: 57
Study 24178916 — intervention group
Group type: COMPARATOR
Intervention: Intermittent cutaneous electric stimulation of the paretic forearm before physiotherapy.
Number of subjects: 57
Study 24178916 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral priming intervention
Number of subjects: 57
Study 22962427 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP) therapy for 3 months
Number of subjects: 59
Study 20450501 — intervention group
Group type: EXPERIMENTAL
Intervention: Tubeless PCNL (Group-I)
Number of subjects: 95
Study 20450501 — intervention group
Group type: COMPARATOR
Intervention: Standard PCNL with nephrostomy tube (Group-II)
Number of subjects: 95
Study 18556716 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting TAXUS stent (PES)
Number of subjects: 396
Study 18556716 — intervention group
Group type: COMPARATOR
Intervention: Vascular brachytherapy (VBT)
Number of subjects: 396
Study 16022966 — intervention group
Group type: EXPERIMENTAL
Intervention: Metyrapone 750 mg x 2
Number of subjects: 36
Study 16022966 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 12367545 — intervention group
Group type: EXPERIMENTAL
Intervention: Swanson silicone trapezium implant
Number of subjects: 26
Study 12367545 — intervention group
Group type: COMPARATOR
Intervention: Tendon interposition arthroplasty (APL)
Number of subjects: 26
Study 10355396 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral dipyridamole
Number of subjects: 0
Study 10355396 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 0
Study 10355396 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyridamole (in 5 patients)
Number of subjects: 0
Study 7478865 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical load applied to the jaw during speech (17% of trials)
Number of subjects: 12
Study 7478865 — intervention group
Group type: COMPARATOR
Intervention: No mechanical load (control)
Number of subjects: 12
Study 1661121 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH) given as a single predialysis bolus injection
Number of subjects: 70
Study 1661121 — intervention group
Group type: COMPARATOR
Intervention: Standard heparin (SH) administered with a continuous infusion
Number of subjects: 70
Study 1661121 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH)
Number of subjects: 70
Study 1661121 — intervention group
Group type: COMPARATOR
Intervention: Standard heparin (SH)
Number of subjects: 70
Study 6807125 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxapram (1‐1.5 mg/kg)
Number of subjects: 0
Study 6807125 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 30636084 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive Ultrasonic Irrigation (PUI)
Number of subjects: 160
Study 30636084 — intervention group
Group type: COMPARATOR
Intervention: Sonic techniques and Conventional Syringe Irrigation (CSI)
Number of subjects: 160
Study 30636084 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups with intracanal SF
Number of subjects: 160
Study 28656922 — intervention group
Group type: EXPERIMENTAL
Intervention: Casein phosphopeptide‐amorphous calcium fluoride phosphate (CPP‐ACFP) applied daily for 4 min for 4 weeks
Number of subjects: 30
Study 28656922 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 30
Study 28656922 — intervention group
Group type: COMPARATOR
Intervention: Comparison between study and control groups
Number of subjects: 30
Study 25125441 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation combined with repetitive task practice therapy
Number of subjects: 40
Study 25125441 — intervention group
Group type: COMPARATOR
Intervention: Sham electrical stimulation combined with repetitive task practice therapy
Number of subjects: 40
Study 25125441 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study 24475821 — intervention group
Group type: EXPERIMENTAL
Intervention: Cancellous bone reconstructions (CBR) and multiplanar reconstructions (MPRs)
Number of subjects: 156
Study 24475821 — intervention group
Group type: COMPARATOR
Intervention: Multiplanar reconstructions (MPRs) alone
Number of subjects: 156
Study 21503389 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise with 50% of 1-RM (E50%)
Number of subjects: 15
Study 21503389 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise with 70% of 1-RM (E70%)
Number of subjects: 15
Study 21503389 — intervention group
Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 15
Study 19659463 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast
Number of subjects: 58
Study 19659463 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study 17288653 — intervention group
Group type: EXPERIMENTAL
Intervention: Videophone support
Number of subjects: 43
Study 17288653 — intervention group
Group type: COMPARATOR
Intervention: Telephone support
Number of subjects: 43
Study 15459834 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycle ergometer test (cyclic muscle activity)
Number of subjects: 15
Study 15459834 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill test (concentric muscle activity)
Number of subjects: 15
Study 15459834 — intervention group
Group type: EXPERIMENTAL
Intervention: Bench‐steptest (eccentric muscle activity)
Number of subjects: 15
Study 15459834 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline urinary 19‐NA and 19‐NE concentrations
Number of subjects: 15
Study 15459834 — intervention group
Group type: EXPERIMENTAL
Intervention: Likert scale of muscle soreness
Number of subjects: 15
Study 15459834 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall exercise mode (eccentric or concentric)
Number of subjects: 15
Study 15459834 — intervention group
Group type: EXPERIMENTAL
Intervention: International Olympic Committee threshold level for nandrolone metabolites
Number of subjects: 15
Study 11895217 — intervention group
Group type: EXPERIMENTAL
Intervention: Digoxin (0.25 mg orally 4x/day for 3 days)
Number of subjects: 12
Study 11895217 — intervention group
Group type: COMPARATOR
Intervention: Enalapril (20 mg/day orally for 3 days)
Number of subjects: 12
Study 11895217 — intervention group
Group type: COMPARATOR
Intervention: Furosemide (20 mg i.v. as a bolus at -5 minutes)
Number of subjects: 12
Study 11895217 — intervention group
Group type: EXPERIMENTAL
Intervention: GHRH + Arginine (0.5 g/kg i.v. from 0 to +30 minutes)
Number of subjects: 12
Study 10090447 — intervention group
Group type: EXPERIMENTAL
Intervention: Latanoprost once daily for the first ten days and dorzolamide three times daily for the second ten days (Group 1)
Number of subjects: 30
Study 10090447 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorzolamide three times daily for the first ten days and latanoprost once daily for the second ten days (Group 2)
Number of subjects: 30
Study 8150527 — intervention group
Group type: EXPERIMENTAL
Intervention: 105AD7 immunization
Number of subjects: 13
Study 8150527 — intervention group
Group type: COMPARATOR
Intervention: Unimmunized patients
Number of subjects: 13
Study 2971619 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 micrograms ANF/min
Number of subjects: 6
Study 2971619 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 micrograms ANF/min
Number of subjects: 6
Study 2971619 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 microgram ANF/min
Number of subjects: 6
Study 2971619 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 31898728 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta transcranial alternating current stimulation (tACS) at 20 Hz, 1 mA peak-to-peak
Number of subjects: 108
Study 31898728 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation (control)
Number of subjects: 108
Study 30658675 — intervention group
Group type: EXPERIMENTAL
Intervention: StresSOS online intervention
Number of subjects: 15000
Study 30658675 — intervention group
Group type: EXPERIMENTAL
Intervention: StresSOS face-to-face intervention
Number of subjects: 15000
Study 30658675 — intervention group
Group type: COMPARATOR
Intervention: Active online control condition
Number of subjects: 15000
Study 28716997 — intervention group
Group type: EXPERIMENTAL
Intervention: Warwick Edinburgh Mental Wellbeing Scale (WEMWBS)
Number of subjects: 221
Study 28716997 — intervention group
Group type: EXPERIMENTAL
Intervention: WEMWBS
Number of subjects: 221
Study 28716997 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimism
Number of subjects: 221
Study 28716997 — intervention group
Group type: EXPERIMENTAL
Intervention: Hope
Number of subjects: 221
Study 25216510 — intervention group
Group type: EXPERIMENTAL
Intervention: LX4211 75 mg once daily
Number of subjects: 299
Study 25216510 — intervention group
Group type: EXPERIMENTAL
Intervention: LX4211 200 mg once daily
Number of subjects: 299
Study 25216510 — intervention group
Group type: EXPERIMENTAL
Intervention: LX4211 200 mg twice daily
Number of subjects: 299
Study 25216510 — intervention group
Group type: EXPERIMENTAL
Intervention: LX4211 400 mg once daily
Number of subjects: 299
Study 25216510 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 299
Study 25216510 — intervention group
Group type: EXPERIMENTAL
Intervention: LX4211
Number of subjects: 299
Study 23474354 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural risk reduction intervention
Number of subjects: 0
Study 23474354 — intervention group
Group type: COMPARATOR
Intervention: Standard care control group
Number of subjects: 0
Study 21518939 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual-focused health promotion intervention
Number of subjects: 0
Study 21518939 — intervention group
Group type: COMPARATOR
Intervention: HIV/STD risk reduction intervention
Number of subjects: 0
Study 18571795 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual acupuncture at Taichong (LV3)
Number of subjects: 10
Study 18571795 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual acupuncture at Xingjian (LV2)
Number of subjects: 10
Study 18571795 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual acupuncture at Neiting (ST44)
Number of subjects: 10
Study 18571795 — intervention group
Group type: COMPARATOR
Intervention: Sham point on the dorsum of the left foot
Number of subjects: 10
Study 16920892 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 0
Study 16920892 — intervention group
Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 0
Study 15258478 — intervention group
Group type: EXPERIMENTAL
Intervention: TLC-CPAP (telephone-linked communications for CPAP) in addition to usual care, n = 15
Number of subjects: 30
Study 15258478 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone, n = 15
Number of subjects: 30
Study 11695801 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemiarthroplasty
Number of subjects: 32
Study 11695801 — intervention group
Group type: COMPARATOR
Intervention: Internal fixation
Number of subjects: 32
Study 9298509 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine (0.003-0.012 mg/kg)
Number of subjects: 0
Study 9298509 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine (0.001-0.01 mg/kg)
Number of subjects: 0
Study 9298509 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette smoking (for human chronic tobacco smokers)
Number of subjects: 0
Study 9298509 — intervention group
Group type: COMPARATOR
Intervention: Saline control injections
Number of subjects: 0
Study 7956382 — intervention group
Group type: EXPERIMENTAL
Intervention: TENS
Number of subjects: 45
Study 7956382 — intervention group
Group type: COMPARATOR
Intervention: Placebo TENS
Number of subjects: 45
Study 7956382 — intervention group
Group type: COMPARATOR
Intervention: Control treatments
Number of subjects: 45
Study 7956382 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 45
Study 3282261 — intervention group
Group type: EXPERIMENTAL
Intervention: Ioversol
Number of subjects: 80
Study 3282261 — intervention group
Group type: COMPARATOR
Intervention: Sodium meglumine diatrizoate (control)
Number of subjects: 80
Study 30324799 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin infiltration (Icon, DMG, Hamburg, Germany)
Number of subjects: 20
Study 28189289 — intervention group
Group type: EXPERIMENTAL
Intervention: Plan‐Study‐Do‐Act (PDSA)‐CQI
Number of subjects: 8
Study 28189289 — intervention group
Group type: EXPERIMENTAL
Intervention: CQI Actions selected by facilities
Number of subjects: 8
Study 27160224 — intervention group
Group type: EXPERIMENTAL
Intervention: (18)F-FDG PET/CT performed before and during treatment
Number of subjects: 55
Study 27160224 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 55
Study 23952107 — intervention group
Group type: EXPERIMENTAL
Intervention: Atraumatic Restorative Treatment (ART)
Number of subjects: 82
Study 23952107 — intervention group
Group type: COMPARATOR
Intervention: Conventional Technique (CT)
Number of subjects: 82
Study 23952107 — intervention group
Group type: EXPERIMENTAL
Intervention: Atraumatic Restorative Treatment (ART) with hygienist
Number of subjects: 82
Study 22075719 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfredson's heel-drop exercise programme
Number of subjects: 58
Study 19176272 — intervention group
Group type: EXPERIMENTAL
Intervention: Goserelin and flutamide (STAD) for 3 or 6 months before and during radiation therapy (66 Gy to the prostate and seminal vesicles)
Number of subjects: 802
Study 19176272 — intervention group
Group type: COMPARATOR
Intervention: Radiation therapy (XRT) alone
Number of subjects: 802
Study 19176272 — intervention group
Group type: EXPERIMENTAL
Intervention: Goserelin and flutamide (STAD)
Number of subjects: 802
Study 19176272 — intervention group
Group type: EXPERIMENTAL
Intervention: Phoenix fail criteria
Number of subjects: 802
Study 19176272 — intervention group
Group type: EXPERIMENTAL
Intervention: ASTRO fail criteria
Number of subjects: 802
Study 17255866 — intervention group
Group type: EXPERIMENTAL
Intervention: Debriefing cards/checklists for bedside teaching
Number of subjects: 0
Study 15500814 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive preparation for video feedback
Number of subjects: 95
Study 15500814 — intervention group
Group type: COMPARATOR
Intervention: Attention-control preparation
Number of subjects: 95
Study 12523868 — intervention group
Group type: COMPARATOR
Intervention: Bilateral ECT (N = 11)
Number of subjects: 24
Study 12523868 — intervention group
Group type: EXPERIMENTAL
Intervention: High-charge right unilateral ECT (N = 13)
Number of subjects: 24
Study 10432873 — intervention group
Group type: EXPERIMENTAL
Intervention: Semiquantitative approach using 10 cytologic criteria rated on a 1-3 scale
Number of subjects: 61
Study 7640931 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantitative computed tomography (QCT)
Number of subjects: 112
Study 7640931 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual X‐ray absorptiometry (DXA)
Number of subjects: 112
Study 7640931 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal QCT
Number of subjects: 112
Study 7640931 — intervention group
Group type: EXPERIMENTAL
Intervention: Total hip DXA
Number of subjects: 112
Study 7640931 — intervention group
Group type: EXPERIMENTAL
Intervention: Ward hip DXA
Number of subjects: 112
Study 7640931 — intervention group
Group type: EXPERIMENTAL
Intervention: Volumetric spinal DXA
Number of subjects: 112
Study 7640931 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal QCT, total and Ward hip DXA, volumetric spinal DXA
Number of subjects: 112
Study 2225508 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics continued for at least 48 hours in patients requiring a tracheotomy
Number of subjects: 0
Study 2225508 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 105622 — intervention group
Group type: EXPERIMENTAL
Intervention: Type B vitamin combination (5 mg/day thiamin HCl and 3 mg/day pyridoxine HCl)
Number of subjects: 0
Study 105622 — intervention group
Group type: EXPERIMENTAL
Intervention: Type C vitamin combination (5 mg/day thiamin HCl and 3 mg/day pyridoxine HCl)
Number of subjects: 0
Study 105622 — intervention group
Group type: COMPARATOR
Intervention: Type A vitamin combination (55 mg/day thiamin HCl and 102 mg/day pyridoxine HCl)
Number of subjects: 0
Study 31870766 — intervention group
Group type: EXPERIMENTAL
Intervention: ECAP-controlled closed-loop spinal cord stimulation
Number of subjects: 134
Study 31870766 — intervention group
Group type: COMPARATOR
Intervention: Fixed-output, open-loop spinal cord stimulation
Number of subjects: 134
Study 31270217 — intervention group
Group type: COMPARATOR
Intervention: Right-cathodal tDCS
Number of subjects: 12
Study 31270217 — intervention group
Group type: COMPARATOR
Intervention: Left-anodal tDCS
Number of subjects: 12
Study 31270217 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 12
Study 28302084 — intervention group
Group type: EXPERIMENTAL
Intervention: EMDR plus treatment as usual (TAU)
Number of subjects: 158
Study 28302084 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU) alone
Number of subjects: 158
Study 28302084 — intervention group
Group type: EXPERIMENTAL
Intervention: EMDR plus TAU
Number of subjects: 158
Study 28302084 — intervention group
Group type: COMPARATOR
Intervention: TAU alone
Number of subjects: 158
Study 25988676 — intervention group
Group type: EXPERIMENTAL
Intervention: Rilpivirine (RPV) long-acting formulation, 300 mg
Number of subjects: 13
Study 25988676 — intervention group
Group type: EXPERIMENTAL
Intervention: Rilpivirine (RPV) long-acting formulation, 600 mg
Number of subjects: 13
Study 25988676 — intervention group
Group type: EXPERIMENTAL
Intervention: Rilpivirine (RPV) long-acting formulation, 1200/600/600 mg
Number of subjects: 13
Study 25988676 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 25159126 — intervention group
Group type: EXPERIMENTAL
Intervention: PREFER (person-centred and integrated Palliative advanced home care and heart Failure care)
Number of subjects: 36
Study 25159126 — intervention group
Group type: EXPERIMENTAL
Intervention: PREFER
Number of subjects: 36
Study 25159126 — intervention group
Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 36
Study 22067758 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline (40 mg daily)
Number of subjects: 65
Study 22067758 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study 19250012 — intervention group
Group type: EXPERIMENTAL
Intervention: Online chat (computer-mediated communication)
Number of subjects: 234
Study 19250012 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face communication
Number of subjects: 234
Study 19250012 — intervention group
Group type: EXPERIMENTAL
Intervention: High trait loneliness (computer-mediated communication)
Number of subjects: 234
Study 17898169 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroids
Number of subjects: 0
Study 17898169 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-13
Number of subjects: 0
Study 17898169 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroids
Number of subjects: 0
Study 15352602 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy (CEA)
Number of subjects: 1739
Study 15352602 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of operation longer than 2 hours
Number of subjects: 1739
Study 11683740 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatostatin-14 (S-14) infusion for 7 days
Number of subjects: 75
Study 9893697 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormonotherapy and chemotherapy
Number of subjects: 0
Study 9893697 — intervention group
Group type: EXPERIMENTAL
Intervention: Taxans (docetaxel, paclitaxel)
Number of subjects: 0
Study 9893697 — intervention group
Group type: EXPERIMENTAL
Intervention: Aromatase inhibitors (letrozole, anastrozole)
Number of subjects: 0
Study 7983288 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimethod educational interventions
Number of subjects: 1140
Study 2303582 — intervention group
Group type: EXPERIMENTAL
Intervention: ibuprofen 800 mg tablets
Number of subjects: 35
Study 2303582 — intervention group
Group type: EXPERIMENTAL
Intervention: ibuprofen 800 mg aqueous suspension
Number of subjects: 35
Study 2303582 — intervention group
Group type: EXPERIMENTAL
Intervention: ibuprofen 800 mg orange juice suspension
Number of subjects: 35
Study 2303582 — intervention group
Group type: COMPARATOR
Intervention: 325 mg aspirin tablets
Number of subjects: 35
Study 2303582 — intervention group
Group type: EXPERIMENTAL
Intervention: ibuprofen suspensions
Number of subjects: 35
Study 2303582 — intervention group
Group type: EXPERIMENTAL
Intervention: ibuprofen tablets
Number of subjects: 35
Study 366897 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined drug treatment (vincristin, 5‐fluoruracil, methotrexate, cyclophosphane, prednisolone)
Number of subjects: 70
Study 366897 — intervention group
Group type: COMPARATOR
Intervention: Combined drug treatment plus ovariectomy and continuous administration of prednisolone, testosterone‐propionate or synoestrol
Number of subjects: 70
Study 31465154 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobil-O-Graph
Number of subjects: 211
Study 31465154 — intervention group
Group type: EXPERIMENTAL
Intervention: Arteriograph
Number of subjects: 211